APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,952,000 | -42.0% | 1,076,548 | +38.8% | 0.05% | -37.0% |
| Q2 2023 | $70,646,000 | -24.1% | 775,480 | -45.1% | 0.08% | -27.0% |
| Q1 2023 | $93,101,000 | +23.2% | 1,411,479 | -3.4% | 0.11% | +24.7% |
| Q4 2022 | $75,582,000 | -22.2% | 1,461,642 | +2.8% | 0.09% | -25.2% |
| Q3 2022 | $97,182,000 | +55.3% | 1,421,535 | +2.7% | 0.12% | +70.0% |
| Q2 2022 | $62,562,000 | -6.8% | 1,383,507 | +4.7% | 0.07% | +37.3% |
| Q1 2022 | $67,149,000 | +9.9% | 1,321,558 | +2.3% | 0.05% | 0.0% |
| Q4 2021 | $61,075,000 | +65.4% | 1,291,783 | +15.3% | 0.05% | +64.5% |
| Q3 2021 | $36,918,000 | +7.0% | 1,120,090 | +105.3% | 0.03% | +10.7% |
| Q2 2021 | $34,487,000 | +37385.9% | 545,674 | +25339.3% | 0.03% | – |
| Q1 2021 | $92,000 | -43.9% | 2,145 | -25.1% | 0.00% | – |
| Q4 2020 | $164,000 | +90.7% | 2,862 | 0.0% | 0.00% | – |
| Q3 2020 | $86,000 | -7.5% | 2,862 | 0.0% | 0.00% | – |
| Q2 2020 | $93,000 | – | 2,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |